Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-16-0263
Abstract: Mutant cystathionine gamma-lyase was targeted to phosphatidylserine exposed on tumor vasculature through fusion with Annexin A1 or Annexin A5. Cystathionine gamma-lyase E58N, R118L, and E338N mutations impart nonnative methionine gamma-lyase activity, resulting in tumor-localized generation…
read more here.
Keywords:
vasculature targeted;
enzyme prodrug;
tumor vasculature;
rapamycin cyclophosphamide ... See more keywords